Computerized Anxiety Treatment for Suicide
| Status: | Completed |
|---|---|
| Conditions: | Anxiety, Psychiatric |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 8/10/2016 |
| Start Date: | October 2013 |
| End Date: | July 2016 |
Suicide Risk Prevention Among Patients With Anxiety Psychopathology
The purpose of this study is to test the effectiveness and usability of multiple
computer-based treatments for mood and anxiety relevant risk factors. The target of the
treatment is related to cognitive stress, which has been shown to be associated with a
variety of negative mental health outcomes such as Post-Traumatic Stress Disorder, suicidal
ideation, and substance use disorders.
computer-based treatments for mood and anxiety relevant risk factors. The target of the
treatment is related to cognitive stress, which has been shown to be associated with a
variety of negative mental health outcomes such as Post-Traumatic Stress Disorder, suicidal
ideation, and substance use disorders.
CATS is a newly developed computerized treatment targeting specific risk factors associated
with anxiety symptoms and suicidal thoughts. Individuals will be asked to complete four
appointments, where they will complete various self-report questionnaires as well as a newly
developed computerized treatment targeting risk factors associated with anxiety.
with anxiety symptoms and suicidal thoughts. Individuals will be asked to complete four
appointments, where they will complete various self-report questionnaires as well as a newly
developed computerized treatment targeting risk factors associated with anxiety.
Inclusion Criteria:
- Meet diagnostic criteria for a primary Axis 1 anxiety disorder or meet diagnostic
criteria for a unipolar mood disorder along with an Axis 1 anxiety disorder.
- Show evidence of current suicidal ideation (BSS above 6.
- Show elevated AS indicated by scoring at or above the community sample mean on the
ASI-Cog (above 9.
Exclusion Criteria:
- No significant medical illness (e.g. sig cardiovascular disease, epilepsy, stroke).
- Current or past psychotic-spectrum disorders or uncontrolled bipolar disorder
- No current substance dependence
- Must be an English speaker.
- Must be 18 years or older.
- Must have normal or corrected vision
- Cannot begin treatment/therapy within 1 month of baseline.
- Cannot begin a new medication within 3 months of baseline.
We found this trial at
1
site
Click here to add this to my saved trials
